bepridil has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Triple-negative breast cancer (TNBC) is the most lethal form of breast cancer." | 1.43 | Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo. ( Berek, JS; Chung, YM; Hu, MC; Ma, J; Park, SH; Yang, Q, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SH | 1 |
| Chung, YM | 1 |
| Ma, J | 1 |
| Yang, Q | 1 |
| Berek, JS | 1 |
| Hu, MC | 1 |
1 other study available for bepridil and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo.
Topics: Animals; Apoptosis; Bepridil; Breast Neoplasms; Cell Nucleus; Dopamine; Female; Forkhead Box Protein | 2016 |